TRACEY REDISH: Open Payments
NPI 1942879465 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,878 in 194 payments from 31 companies in 2025. Trend: 2023 $1,823 · 2024 $3,184 · 2025 $3,878
Food & beverage: $3,878
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 20 | $349 |
| UCB, Inc. | 21 | $344 |
| Lundbeck LLC | 15 | $311 |
| Alexion Pharmaceuticals, Inc. | 9 | $276 |
| Novartis Pharmaceuticals Corporation | 12 | $272 |
| Celgene Corporation | 11 | $197 |
| Teva Pharmaceuticals USA, Inc. | 10 | $196 |
| PFIZER INC. | 12 | $192 |
| Genentech USA, Inc. | 9 | $185 |
| Amneal Pharmaceuticals LLC | 8 | $170 |
Products named: Leqembi, KESIMPTA, ULTOMIRIS, REXULTI, ZEPOSIA, Ocrevus Zunovo, CREXONT, Briviact.
Industry payments across AZ — which companies pay providers there.
